All News

Eric Dein Tweet
ericdeinmd
#RNL2023 Rob Spiera: I often use aspirin a day, especially if cranial complications and no contra-indications" No prospective studies, 2 large retrospective studies suggesting benefit @RheumNow https://t.co/OedVG03yN3
Eric Dein Tweet
ericdeinmd
Is there role for MTX in GCA Favorable results in a meta-analysis with NNT 11 to prevent 1 cranial relapse BUT: limitations of meta-analysis, short follow-up, dose response not evaluated Robert Spiera at #RNL2023 @RheumNow https://t.co/sHx2ceVmAi
Eric Dein Tweet
ericdeinmd
DMARDs/TNF for PMR: MTX- initial benefit, but no 5 year steroid sparing effect Infliximab - no benefit Lef - some benefit in case series Robert Spiera #RNL2023 @RheumNow https://t.co/cmwGEWHQEO
Eric Dein Tweet
ericdeinmd
IL-6 for PMR SPARE and SEMAPORE (Toci), SAPHYR (Sari) 2/2023: FDA approves sarilumab for PMR for inadequate response to corticosteroids or unable to taper off Robert Spiera @RheumNow #RNL2023 https://t.co/quOWjJjgB3
Robert B Chao, MD Tweet
doctorRBC
Dr. Robert Spiera on Recent IL-6i in PMR treatment: SPARE and SEMAPHORE study - Tocilizumab SAPHYR - Sarilumab (now FDA approved for PMR tx) @RheumNow #RNL2023 https://t.co/gofe54wSjo
Eric Dein Tweet
ericdeinmd
SAPHYR, presented at #ACR22, unpublished Robert Spiera at #RNL2023 Phase 3 study for refractory PMR Sustained remission of disease, less steroids usage, steroid toxicity, and improved PROs @RheumNow https://t.co/k3w2TQ3yEB
Dr. Rachel Tate Tweet
uptoTate
I use US in my practice and since this data was presented last year, I’ve been evaluating subacromial/deltoid bursas my PMR patients. ⁦@anisha_dua⁩ reviews imaging at #RNL2023 ⁦@RheumNow⁩ https://t.co/1TYdXNmcx0
Robert B Chao, MD Tweet
doctorRBC
Dr. Anisha Dua on Imaging in PMR: - US of shoulders to eval for bursitis can increase specificity - MRI better for pelvic girdle, but expensive - Consider PET if lack of response to steroids, r/o malignancy #RNL2023 @RheumNow https://t.co/4yszV9KMA9
Eric Dein Tweet
ericdeinmd
#RNL2023 @anisha_dua: Temporary artery biopsy still preferred, rec over u/s, especially if not Early imaging for GCA recommended @RheumNow https://t.co/41fiQuj2x9
Dr Gurdeep Dulay Tweet
gurdeep_dulay
A reminder by @anisha_dua ➡️15% #PMR patients get #GCA ➡️ up to 50% GCA patients get PMR #RNL2023
Eric Dein Tweet
ericdeinmd
GCA biopsy: When and How Early is best, rec'd in first 2 weeks. Findings can be present at 8 weeks but be less prominent @anisha_dua rec's unilateral imaging in most pts, especially w scalp tenderness on one side >1 cm length #RNL2023 @RheumNow https://t.co/HBHBGeFm6J
Eric Dein Tweet
ericdeinmd
@anisha_dua Table on imaging in LVV U/S: increase specificity for PMR, operator dependent CTA: high detail, contrast + radiation MRA: cost and limitations in CKD, metal PET/CT: useful but not specific for vasculitis and very high cost #RNL2023 @RheumNow https://t.co/aTdrlPfN9J
Eric Dein Tweet
ericdeinmd
@RheumNow Live 2023 Starts Tomorrow! Or does it start earlier? Love that there is a pre-learn and pre-test to set the stage for #RNL2023 Excited for this talk by @anisha_dua on assessment for GCA/PMR #RheumTwitter https://t.co/VcawlnaPFf
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×